期刊
NUTRITIONAL NEUROSCIENCE
卷 26, 期 10, 页码 942-952出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/1028415X.2022.2110664
关键词
Probiotics; BDNF; meta-analysis; systematic review; Bifidobacterium; depression; Lactobacillus; microbium; gut microbiota
This systematic review and meta-analysis found that probiotics supplementation may be effective in elevating brain-derived neurotrophic factor (BDNF) levels in patients with depression and neurological disorders. A mixture of Lactobacillus and Bifidobacterium genera appeared to show greater efficacy than single genus supplements. However, the low quality of evidence suggests the need for more large-scale, high-quality randomized controlled trials for reliable conclusions.
Background and aims An emerging body of evidence has demonstrated the beneficial effects of probiotics on various mental health conditions. In this systematic review and meta-analysis, we sought to examine the effects of probiotics supplementation on brain-derived neurotrophic factor (BDNF) in adults. Methods PubMed, Scopus, ISI Web of Science, and the Cochrane Library were searched, from database inception to April 2021, for eligible randomized controlled trials (RCTs). We pooled mean differences and standard deviations from RCTs using random-effect models. Results Overall, meta-analysis of 11 trials (n = 648 participants) showed no significant changes in serum level of BDNF following probiotics. However, subgroup analysis revealed that probiotics increased BDNF levels in individuals suffering from neurological disorders (n = 214 participants; WMD = 3.08 ng/mL, 95% CI: 1.83, 4.34; P = 0.001; I-2 = 7.5%; P-heterogeneity 0.34), or depression (n = 268 participants; WMD = 0.77 ng/mL, 95% CI: 0.07, 1.47; P = 0.032; I-2 = 88.4%; P-heterogeneity < 0.001). Furthermore, a significant increase in BDNF levels was found in studies that administered the mixture of Lactobacillus and Bifidobacterium genera, and were conducted in Asia . Conclusion Our main findings suggest that probiotics may be effective in elevating BDNF levels in patients with depression and neurological disorders, and a mixed of Lactobacillus and Bifidobacterium appear to show greater efficacy than the single genus supplement. The low quality of evidence reduces clinical advocacy, and indicates that more large-scale, high-quality, RCTs are needed to facilitate reliable conclusions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据